Media & Advertising
Venaxis' APPY1 Test Passes Futility Analysis in Pivotal Clinical Study
Have an interest in this Story?
Sign Up for Real-Time email updates
July 15, 2013
SOURCE Venaxis, Inc. Company Provides Clinical and Corporate Update Company to Host Conference Call and Webcast Tuesday, July 16, 2013, 8:30 a.m. ET CASTLE ROCK, Colo. The futility analysis, which consisted of an independent review of the validity, integrity, and clinical and scientific relevan...
Read Full Article
Leave a Comment:
You must be logged in to leave a comment
Most Read Biotech Articles
China Automobile Steering Device Market, Rental Survey in Automobile Industry of
African Lions Rescued from Mexico
Brazil Precious Metals Mining Market 2020 Forecasts for Gold and Silver
Marijuana Legalization: Myths And Politics Debunked By Former White House Drug
Petitioning Candidate for U.S. Congress 2014 John Pistone "People Over Party Politics"
Broker - Owner
Real Estate Industry
Senior Vice President
View more profiles
Access dozens of premium and subscriptions sites
Build a News Circle
Get News Briefings
Congoo News Home
Get the Netpass
Copyright ©2014 Congoo.com. All Rights Reserved.